amantadine has been researched along with Leukemia L 1210 in 5 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, HT | 2 |
| Elberling, JA | 2 |
| Shirota, FN | 2 |
| Mathé, G | 1 |
| Schwarzenberg, L | 1 |
| Amiel, JL | 1 |
| Pouillart, P | 1 |
| Hayat, M | 1 |
| de Vassal, F | 1 |
| Rosenfeld, C | 1 |
| Jasmin, C | 1 |
| Cates, LA | 2 |
| Gallio, RL | 2 |
| Cramer, MB | 1 |
1 trial available for amantadine and Leukemia L 1210
| Article | Year |
|---|---|
New experimental and clinical data on leukaemia immunotherapy.
Topics: Adolescent; Adult; Amantadine; Animals; Bacterial Vaccines; BCG Vaccine; Cell Line; Central Nervous | 1975 |
4 other studies available for amantadine and Leukemia L 1210
| Article | Year |
|---|---|
Latentiated forms of the transport-inhibitory alpha-amino acid adamantanine.
Topics: Amantadine; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; gamma-Glutamyltransferase | 1980 |
Potential latentiation forms of biologically active compounds based on action of leucine aminopeptidase. Dipeptide derivatives of the tricycloaliphatic alpha-amino acid, adamantanine.
Topics: Amantadine; Animals; Biological Availability; Dipeptides; Hydrolysis; Kinetics; Leucyl Aminopeptidas | 1975 |
Phosphorus-nitrogen compounds XVI: phosphoramantadine derivatives.
Topics: Amantadine; Animals; Leukemia L1210; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Method | 1974 |
Phosphorus--nitrogen compounds. XV. N-1-adamantylphosphoramidic dichloride and dimethyl and diphenyl N-1-adamantylphosphoramidate.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Guinea Pigs; Leukemia L1210; Magnetic Resonance | 1973 |